Phase 1 Oedema Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
Hereditary Angioedema (HAE)AngioedemaBradykinin-mediated Angioedema+1 more
Institute for Asthma and Allergy10 enrolled1 locationNCT07046806
Completed
Phase 1
An open-label, multiple dose study to compare the single-dose and steady-state pharmacokinetics of a 40 mg PHA-022121 extended-release (XR) tablet administered once daily between healthy Japanese, Chinese, and Caucasian volunteers.
Hereditary Angioedema (HAE)
Pharvaris Netherlands B.V.36 enrolled1 locationACTRN12623000736640
Terminated
Phase 1
Safety, tolerability and pharmacokinetics of extended release formulations of ATN-249 in healthy volunteers when dosed once a day or over several days
Hereditary Angioedema
LifeSci Pharmaceuticals, inc.24 enrolled1 locationACTRN12618001417279
Completed
Phase 1
Safety, tolerability, pharmacokinetics and food effect of ATN-249 in healthy volunteers
Hereditary Angioedema
LifeSci Pharmaceuticals, inc.48 enrolled1 locationACTRN12618000430235
Completed
Phase 1
A Phase 1, Safety and Pharmacokinetic Study of CSL312 in Healthy Subjects
Hereditary Angioedema
CSL Limited48 enrolled1 locationACTRN12616001438448